Aventis' Allegra Patent Survives Impax Assault

Law360, New York (June 22, 2010, 4:06 PM EDT) -- A federal judge has refused to reconsider a decision to reinstate a patent for allergy drug Allegra in a long-running infringement suit brought by Aventis Pharmaceuticals Inc. and others against Impax Laboratories Inc., Mylan Pharmaceuticals Inc. and Dr. Reddy’s Laboratories Inc.

Judge Garrett E. Brown Jr. of the U.S. District Court for the District of New Jersey said Monday that he would not reconsider a February 2010 decision to vacate a 2005 finding that two claims of one of the asserted patents in the case were...
To view the full article, register now.